Centre for Research on Health Economics, Social and Health Care Management (CREMS), Università Carlo Cattaneo - LIUC, Castellanza (VA), Italy.
Acta Trop. 2010 Mar;113(3):279-84. doi: 10.1016/j.actatropica.2009.11.011. Epub 2009 Dec 3.
Following preventive chemotherapy covering the entire population in the two endemic regions in Cambodia, the prevalence of schistosomiasis dropped from 77% in 1995 to 0.5% in 2003. The study presented here reports on the running cost of the control programme, and evaluates its cost-effectiveness and cost-benefit. Financial costs were assessed using data taken from the annual reports of the National Center for Malaria Control, the Cambodian institution responsible for the control activities. Other data were collected from interviews with provincial and district staff. The analysis was conducted from the point of views of the Cambodian Ministry of Health and that of the society, and the comparison was undertaken using the "do-nothing" option. The cost to treat an individual for the 9 years period of the implementation phase was 9.22 USD (1.02 per year), the cost for each severe infection avoided was 61.50 USD and 6531 USD for each death avoided. The drug cost corresponds on average to 17.34% of the programme's implementation cost. The cost of bringing one severely infected individual of productive age to complete productivity, was estimated at 114 USD and for 1 USD invested in the programme the return in increased productivity, for the economic system, was estimated to be 3.85 USD. The control programme demonstrated significant economical advantages. However, its costs are too high to be entirely supported by the Cambodian Ministry of Health.
在柬埔寨两个流行地区为全体人口实施预防化疗之后，血吸虫病的流行率从 1995 年的 77%下降到 2003 年的 0.5%。本研究报告介绍了控制规划的运行成本，并对其成本效益和成本效益进行了评估。财务成本是利用国家疟疾控制中心（负责控制活动的柬埔寨机构）的年度报告中的数据进行评估的。其他数据是从与省和地区工作人员的访谈中收集的。分析从柬埔寨卫生部和社会的角度进行，并使用“不作为”选项进行了比较。在实施阶段的 9 年期间，治疗一个人的费用为 9.22 美元（每年 1.02 美元），每避免一次严重感染的费用为 61.50 美元，每避免一次死亡的费用为 6531 美元。药物成本平均占该计划实施成本的 17.34%。将一个处于生产年龄的严重感染个体恢复到完全生产能力的成本估计为 114 美元，而投资 1 美元于该计划，从经济系统来看，预计增加的生产力回报为 3.85 美元。控制规划显示出显著的经济优势。然而，其成本太高，无法完全由柬埔寨卫生部承担。
